Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 140th ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
CING	CINGULATE INC	$17.83M	-229.80%	-142.30%	-238.91%	-626.10%	1.10	1.87	N/A	N/A	N/A
QURE	UNIQURE NV	$839.84M	-483.90%	-34.30%	-26.81%	-19.90%	16.97	11.99	54.00%	-1,077.10%	-755.18%
SYRE	SPYRE THERAPEUTICS INC	$1.04B	-49.10%	-41.10%	-41.86%	-53.00%	0.18	8.06	N/A	N/A	N/A
CRVO	CERVOMED INC	$61.96M	-44.10%	-40.60%	-53.91%	-56.50%	0.11	9.78	100.00%	-200.60%	-200.58%
DNA	GINKGO BIOWORKS HOLDINGS INC	$523.27M	-63.10%	-32.70%	-40.11%	-41.90%	1.00	4.88	80.00%	-198.80%	-198.98%
ALDX	ALDEYRA THERAPEUTICS INC	$166.51M	-72.60%	-52.30%	-70.70%	-122.90%	0.47	6.49	N/A	N/A	N/A
OTLK	OUTLOOK THERAPEUTICS INC	$61.09M	-35.30%	75.40%	-367.87%	414.00%	-1.59	0.72	N/A	N/A	N/A
ROIV	ROIVANT SCIENCES LTD	$7.70B	-3.40%	-2.90%	-2.34%	-4.50%	0.05	33.47	96.90%	-592.00%	-426.14%
QNRX	QUOIN PHARMACEUTICALS LTD	$8.63M	-149.00%	-77.20%	-128.99%	-187.80%	1.19	2.57	N/A	N/A	N/A
MAZE	MAZE THERAPEUTICS INC	$586.88M	N/A	N/A	N/A	N/A	0.14	16.10	N/A	N/A	N/A
PHAT	PHATHOM PHARMACEUTICALS INC	$742.82M	N/A	-100.30%	-123.94%	-53.20%	-1.87	3.58	86.20%	-422.40%	-333.35%
SPRY	ARS PHARMACEUTICALS INC	$1.51B	-6.90%	-5.60%	-5.13%	-6.20%	0.43	11.00	97.90%	-16.10%	-15.82%
IBIO	IBIO INC	$15.33M	-130.50%	-89.30%	-151.50%	-244.90%	0.68	1.12	100.00%	-5,597.90%	-5,537.07%
SVRA	SAVARA INC	$381.97M	-65.90%	-52.40%	-57.59%	-53.80%	0.28	14.91	N/A	N/A	N/A
ANRO	ALTO NEUROSCIENCE INC	$65.24M	-39.80%	-34.20%	-37.38%	-415.50%	0.24	22.53	N/A	N/A	N/A
KTTA	PASITHEA THERAPEUTICS CORP	$5.85M	-88.10%	-81.20%	-104.16%	3,238.60%	0.13	3.84	N/A	N/A	N/A
IOBT	IO BIOTECH INC	$88.94M	-162.60%	-125.10%	-354.39%	1,698.90%	0.73	2.32	N/A	N/A	N/A
CRVS	CORVUS PHARMACEUTICALS INC	$323.11M	-113.80%	-65.80%	-82.54%	-141.10%	0.21	4.90	N/A	N/A	N/A
NNVC	NANOVIRICIDES INC	$24.27M	-95.40%	-84.30%	-110.12%	-160.10%	0.14	2.28	N/A	N/A	N/A
STRO	SUTRO BIOPHARMA INC	$67.48M	-347.60%	-59.50%	-116.00%	-133.70%	-13.45	2.16	100.00%	-369.10%	-328.94%
ACET	ADICET BIO INC	$62.03M	-59.10%	-50.70%	-67.11%	-93.10%	0.19	9.34	N/A	N/A	N/A
SNDX	SYNDAX PHARMACEUTICALS INC	$881.99M	-101.60%	-58.40%	-58.28%	-60.20%	1.98	5.80	96.10%	-757.50%	-727.96%
ALEC	ALECTOR INC	$153.99M	-100.60%	-25.10%	-41.31%	-34.50%	3.32	3.34	100.00%	-139.70%	-139.60%
TARA	PROTARA THERAPEUTICS INC	$121.15M	-36.40%	-33.30%	-28.11%	-133.30%	0.06	18.03	N/A	N/A	N/A
BEAM	BEAM THERAPEUTICS INC	$1.72B	-44.20%	-31.00%	-29.22%	-42.80%	0.31	8.81	100.00%	-609.20%	-609.18%
RVMD	REVOLUTION MEDICINES INC	$7.56B	-37.10%	-32.80%	-31.64%	-41.40%	0.14	13.46	N/A	N/A	N/A
DMAC	DIAMEDICA THERAPEUTICS INC	$156.52M	-61.30%	-55.50%	-78.86%	-69.80%	0.14	8.02	N/A	N/A	N/A
IOVA	IOVANCE BIOTHERAPEUTICS INC	$748.01M	-49.70%	-39.20%	-44.86%	-85.40%	0.26	4.18	21.70%	-176.50%	-178.03%
XBIT	XBIOTECH INC	$80.49M	-21.10%	-19.60%	-22.07%	-188.30%	0.04	29.15	N/A	N/A	N/A
ARDX	ARDELYX INC	$861.32M	-34.40%	-13.80%	-11.34%	-9.50%	1.82	4.12	84.60%	-14.90%	-10.48%
IRON	DISC MEDICINE INC	$1.86B	-22.60%	-21.10%	-16.59%	-32.70%	0.07	37.65	N/A	N/A	N/A
PCVX	VAXCYTE INC	$4.46B	-17.10%	-16.30%	-15.53%	-20.40%	0.06	17.70	N/A	N/A	N/A
VSTM	VERASTEM INC	$307.72M	N/A	-128.00%	-150.99%	-447.30%	-5.06	3.50	100.00%	-1,488.80%	-1,450.68%
SRRK	SCHOLAR ROCK HOLDING CORP	$3.08B	-118.20%	-82.00%	-71.40%	-117.50%	0.31	10.25	N/A	N/A	N/A
MURA	MURAL ONCOLOGY PLC	$42.48M	-83.40%	-70.70%	-120.02%	-244.80%	0.22	5.08	N/A	N/A	N/A
CRNX	CRINETICS PHARMACEUTICALS INC	$2.98B	-30.90%	-28.10%	-25.17%	-35.80%	0.09	22.53	100.00%	-43,191.10%	-43,191.05%
KYTX	KYVERNA THERAPEUTICS INC	$139.16M	-51.60%	-45.90%	-63.90%	-73.70%	0.16	7.44	N/A	N/A	N/A
ANVS	ANNOVIS BIO INC	$54.76M	-300.60%	-193.50%	-119.92%	2,241.60%	0.11	10.68	N/A	N/A	N/A
THRD	THIRD HARMONIC BIO INC	$245.04M	-19.30%	-18.70%	-19.45%	-952.20%	0.03	54.10	N/A	N/A	N/A
TVGN	TEVOGEN BIO HOLDINGS INC	$228.03M	N/A	-843.10%	685.32%	720.00%	-1.53	0.35	N/A	N/A	N/A
VYGR	VOYAGER THERAPEUTICS INC	$182.61M	-27.40%	-21.10%	-26.84%	-28.50%	0.30	6.10	100.00%	-140.00%	-138.89%
IMRX	IMMUNEERING CORP	$68.37M	-119.20%	-99.20%	-135.55%	-718.20%	0.21	7.48	N/A	N/A	N/A
TYRA	TYRA BIOSCIENCES INC	$554.65M	-27.50%	-26.10%	-29.29%	-36.60%	0.06	22.78	N/A	N/A	N/A
ELVN	ENLIVEN THERAPEUTICS INC	$1.08B	-31.80%	-30.10%	-32.78%	-49.30%	0.05	21.07	N/A	N/A	N/A
RANI	RANI THERAPEUTICS HOLDINGS INC	$30.21M	-2,437.00%	-80.50%	-628.76%	-58.10%	-9.65	0.88	100.00%	-2,483.20%	-2,093.25%
OSTX	OS THERAPIES INC	$51.14M	N/A	-405.00%	-1,412.11%	204.60%	-0.87	1.16	N/A	N/A	N/A
PTIX	PROTAGENIC THERAPEUTICS INC	$1.96M	-860.50%	-354.10%	5,933.56%	929.50%	-12.19	0.86	N/A	N/A	N/A
OLMA	OLEMA PHARMACEUTICALS INC	$285.32M	-42.30%	-38.30%	-33.60%	-52.40%	0.07	15.22	N/A	N/A	N/A
APVO	APTEVO THERAPEUTICS INC	$1.78M	-779.40%	-175.60%	-803.80%	-406.40%	-6.66	0.67	N/A	N/A	N/A
ACLX	ARCELLX INC	$3.64B	-35.30%	-22.70%	-36.07%	-35.20%	0.56	4.93	100.00%	-211.50%	-251.56%
PRQR	PROQR THERAPEUTICS NV	$202.50M	-53.60%	-22.20%	-24.81%	-756.50%	0.92	4.10	100.00%	-153.80%	-149.12%
TNYA	TENAYA THERAPEUTICS INC	$96.30M	-92.20%	-74.50%	-81.48%	-96.90%	0.21	6.68	N/A	N/A	N/A
RZLT	REZOLUTE INC	$359.18M	-70.10%	-63.10%	-86.68%	-89.10%	0.15	8.43	N/A	N/A	N/A
BCAX	BICARA THERAPEUTICS INC	$591.17M	N/A	N/A	N/A	N/A	0.04	24.62	N/A	N/A	N/A
ALMS	ALUMIS INC	$170.83M	-406.30%	-107.30%	-170.95%	-245.10%	0.55	3.73	100.00%	-1,974.50%	-1,974.51%
AURA	AURA BIOSCIENCES INC	$322.73M	-58.60%	-49.70%	-66.05%	-57.50%	0.21	11.06	N/A	N/A	N/A
APLS	APELLIS PHARMACEUTICALS INC	$2.37B	-100.10%	-25.60%	-28.28%	-22.80%	3.92	4.08	83.00%	-28.80%	-22.93%
FDMT	4D MOLECULAR THERAPEUTICS INC	$203.37M	-33.30%	-30.70%	-36.09%	-43.50%	0.10	12.36	100.00%	-767,126.10%	-767,126.09%
NTLA	INTELLIA THERAPEUTICS INC	$860.78M	-58.70%	-46.30%	-60.20%	-51.60%	0.26	4.90	100.00%	-1,154.10%	-1,154.10%
SGMT	SAGIMET BIOSCIENCES INC	$266.26M	-35.20%	-34.10%	-41.09%	-68.10%	0.05	20.34	N/A	N/A	N/A
BCTX	BRIACELL THERAPEUTICS CORP	$11.57M	N/A	-147.90%	27.34%	-75.60%	1.90	1.37	N/A	N/A	N/A
TELO	TELOMIR PHARMACEUTICALS INC	$58.33M	-2,009.60%	-1,009.70%	7,774.94%	2,642.40%	-4.05	0.75	N/A	N/A	N/A
CRSP	CRISPR THERAPEUTICS AG	$3.57B	-20.10%	-17.10%	-18.65%	-18.60%	0.18	15.64	100.00%	-1,023.60%	-1,013.10%
ARTV	ARTIVA BIOTHERAPEUTICS INC	$48.24M	-78.50%	-40.80%	-40.05%	-49.60%	0.13	13.93	N/A	N/A	N/A
VERA	VERA THERAPEUTICS INC	$1.45B	-40.60%	-34.50%	-28.55%	-34.30%	0.14	27.68	N/A	N/A	N/A
NKTX	NKARTA INC	$131.98M	-26.60%	-21.60%	-24.62%	-21.80%	0.24	14.48	N/A	N/A	N/A
VRDN	VIRIDIAN THERAPEUTICS INC	$1.30B	-49.10%	-44.70%	-48.67%	-56.50%	0.09	19.49	100.00%	-102,092.40%	-101,084.11%
ONCY	ONCOLYTICS BIOTECH INC	$52.54M	-316.30%	-131.00%	-225.15%	8,462.00%	2.03	3.21	N/A	N/A	N/A
IMTX	IMMATICS NV	$743.89M	-4.60%	-3.40%	-3.04%	-5.20%	0.20	10.28	100.00%	-15.00%	-12.34%
JANX	JANUX THERAPEUTICS INC	$1.47B	-9.30%	-8.90%	-7.52%	-10.40%	0.04	58.47	100.00%	-832.70%	-832.71%
NUVL	NUVALENT INC	$5.62B	-31.30%	-29.30%	-29.14%	-37.80%	0.09	14.48	N/A	N/A	N/A
KALV	KALVISTA PHARMACEUTICALS INC	$644.31M	-106.80%	-80.60%	-67.41%	-128.10%	0.90	10.44	N/A	N/A	N/A
ABOS	ACUMEN PHARMACEUTICALS INC	$64.81M	-58.20%	-46.50%	-60.57%	-51.70%	0.32	8.02	N/A	N/A	N/A
AGIO	AGIOS PHARMACEUTICALS INC	$1.99B	50.30%	46.10%	47.25%	54.50%	0.06	18.50	87.50%	1,798.30%	1,917.72%
IMVT	IMMUNOVANT INC	$2.68B	-80.60%	-71.90%	-58.37%	2,444.00%	0.10	11.16	N/A	N/A	N/A
ALXO	ALX ONCOLOGY HOLDINGS INC	$27.36M	-104.40%	-77.70%	-125.60%	-96.70%	0.37	5.47	N/A	N/A	N/A
AVBP	ARRIVENT BIOPHARMA INC	$796.13M	-49.30%	-46.70%	-62.93%	-154.70%	0.06	14.34	N/A	N/A	N/A
IMUX	IMMUNIC INC	$77.13M	-326.90%	-181.30%	1,898.68%	558.80%	-4.88	0.74	N/A	N/A	N/A
CGEM	CULLINAN THERAPEUTICS INC	$508.12M	-29.70%	-28.40%	-32.34%	-34.60%	0.05	11.62	N/A	N/A	N/A
RCKT	ROCKET PHARMACEUTICALS INC	$315.67M	-64.90%	-56.10%	-58.78%	-85.00%	0.14	9.19	N/A	N/A	N/A
LGVN	LONGEVERON INC	$19.51M	-128.50%	-106.90%	-93.38%	-560.50%	0.22	5.61	82.30%	-1,149.40%	-760.63%
CYTK	CYTOKINETICS INC	$4.11B	N/A	-43.70%	-52.14%	-29.40%	-5.75	5.99	100.00%	-3,201.50%	-2,996.11%
ENGN	ENGENE HOLDINGS INC	$170.18M	-32.60%	-28.30%	-30.82%	-49.30%	0.17	12.67	N/A	N/A	N/A
KPTI	KARYOPHARM THERAPEUTICS INC	$37.93M	N/A	-36.00%	-53.47%	-8.80%	-1.62	1.33	96.20%	-44.00%	-14.05%
CYBN	CYBIN INC	$167.01M	-39.00%	-37.70%	-43.25%	-841.30%	0.06	12.60	N/A	N/A	N/A
CRBP	CORBUS PHARMACEUTICALS HOLDINGS INC	$108.05M	-36.90%	-32.90%	-38.39%	-39.80%	0.10	11.82	N/A	N/A	N/A
SLXN	SILEXION THERAPEUTICS CORP	$7.61M	N/A	-319.50%	-207.97%	-362.70%	2.21	3.22	N/A	N/A	N/A
PLRZ	POLYRIZON LTD	$14.01k	-60.60%	-50.60%	-24.63%	-2,578.20%	0.05	10.17	N/A	N/A	N/A
CLYM	CLIMB BIO INC	$85.15M	-43.90%	-42.90%	-48.00%	-102.60%	0.04	14.25	N/A	N/A	N/A
DNTH	DIANTHUS THERAPEUTICS INC	$588.85M	-29.30%	-27.90%	-30.38%	-40.00%	0.06	15.99	100.00%	-1,544.00%	-1,544.02%
SANA	SANA BIOTECHNOLOGY INC	$584.19M	-76.50%	-39.30%	-50.61%	-81.20%	1.13	3.40	N/A	N/A	N/A
ZNTL	ZENTALIS PHARMACEUTICALS INC	$96.42M	-65.50%	-51.00%	-66.99%	-59.00%	0.30	6.94	100.00%	552.70%	552.64%
PHVS	PHARVARIS NV	$910.04M	-54.40%	-50.70%	N/A	-1,673.40%	0.10	N/A	N/A	N/A	N/A
GRI	GRI BIO INC	$2.78M	-331.30%	-202.60%	-743.15%	753.30%	2.35	1.41	N/A	N/A	N/A
TPST	TEMPEST THERAPEUTICS INC	$24.34M	-305.50%	-119.70%	-230.10%	-316.80%	1.89	1.70	N/A	N/A	N/A
MGX	METAGENOMI INC	$53.46M	-32.10%	-22.80%	-32.32%	-27.50%	0.40	5.85	100.00%	-172.20%	-184.18%
DSGN	DESIGN THERAPEUTICS INC	$217.99M	-22.90%	-22.00%	-24.52%	-25.40%	0.04	28.37	N/A	N/A	N/A
FBLG	FIBROBIOLOGICS INC	$30.95M	-564.30%	-64.90%	-237.98%	520.60%	3.86	1.14	N/A	N/A	N/A
GUTS	FRACTYL HEALTH INC	$100.89M	-228.70%	-76.70%	-138.71%	-102.70%	12.03	2.50	48.30%	-148,511.70%	-148,511.67%
DNLI	DENALI THERAPEUTICS INC	$2.11B	-35.90%	-32.40%	-38.48%	-36.00%	0.13	9.56	N/A	N/A	N/A

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Jun 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Aurinia Pharmaceuticals (NASDAQ:AUPH)

Aurinia Pharmaceuticals (NASDAQ:AUPH) is the #1 top biotech stock out of 653 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Aurinia Pharmaceuticals (NASDAQ:AUPH) is: Value: B, Growth: B, Momentum: C, Sentiment: A, Safety: C, Financials: A, and AI: C.

Aurinia Pharmaceuticals (NASDAQ:AUPH) has a Due Diligence Score of 62, which is 38 points higher than the biotech industry average of 24.

AUPH passed 20 out of 33 due diligence checks and has strong fundamentals. Aurinia Pharmaceuticals has seen its stock return 52.9% over the past year, overperforming other biotech stocks by 129 percentage points.

2. Exelixis (NASDAQ:EXEL)

Exelixis (NASDAQ:EXEL) is the #2 top biotech stock out of 653 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Exelixis (NASDAQ:EXEL) is: Value: A, Growth: C, Momentum: C, Sentiment: A, Safety: C, Financials: A, and AI: C.

Exelixis (NASDAQ:EXEL) has a Due Diligence Score of 67, which is 43 points higher than the biotech industry average of 24.

EXEL passed 22 out of 33 due diligence checks and has strong fundamentals. Exelixis has seen its stock return 89.39% over the past year, overperforming other biotech stocks by 166 percentage points.

Exelixis has an average 1 year price target of $39.94, a downside of -3.97% from Exelixis's current stock price of $41.59.

Exelixis stock has a consensus Buy recommendation according to Wall Street analysts. Of the 16 analysts covering Exelixis, 31.25% have issued a Strong Buy rating, 18.75% have issued a Buy, 50% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Catalyst Pharmaceuticals (NASDAQ:CPRX)

Catalyst Pharmaceuticals (NASDAQ:CPRX) is the #3 top biotech stock out of 653 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Catalyst Pharmaceuticals (NASDAQ:CPRX) is: Value: A, Growth: C, Momentum: C, Sentiment: A, Safety: D, Financials: A, and AI: C.

Catalyst Pharmaceuticals (NASDAQ:CPRX) has a Due Diligence Score of 73, which is 49 points higher than the biotech industry average of 24.

CPRX passed 24 out of 33 due diligence checks and has strong fundamentals. Catalyst Pharmaceuticals has seen its stock return 53.49% over the past year, overperforming other biotech stocks by 130 percentage points.

Catalyst Pharmaceuticals has an average 1 year price target of $32.50, an upside of 38.12% from Catalyst Pharmaceuticals's current stock price of $23.53.

Catalyst Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Catalyst Pharmaceuticals, 50% have issued a Strong Buy rating, 50% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 5 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 6.58%, which is 5 percentage points higher than the biotech industry average of 1.63%.

Dominari Holdings's dividend payout ratio of -7.1% indicates that its high dividend yield might not be sustainable for the long-term.

2. Novo Nordisk (Ozempic) (NYSE:NVO)

Novo Nordisk (Ozempic) (NYSE:NVO) has an annual dividend yield of 2.02%, which is the same as the biotech industry average of 1.63%. Novo Nordisk (Ozempic)'s dividend payout is not stable, having dropped more than 10% ten times in the last 10 years. Novo Nordisk (Ozempic)'s dividend has shown consistent growth over the last 10 years.

Novo Nordisk (Ozempic)'s dividend payout ratio of 45.2% indicates that its dividend yield is sustainable for the long-term.

3. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 1.87%, which is the same as the biotech industry average of 1.63%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 34.4% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks down?

Biotech stocks were down -1.4% in the last day, and down -1.07% over the last week. Biorestorative Therapies was the among the top losers in the biotechnology industry, dropping -16% yesterday.

BioRestorative Therapies shares are trading lower. The company announced the presentation of promising preliminary blinded data from the first 36 subjects in its ongoing Phase 2 clinical trial of BRTX-100.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 28 points higher than the biotech industry average of 15. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has gained 0.9% in the past year. It has overperformed other stocks in the biotech industry by 77 percentage points.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 56 points higher than the biotech industry average of 15. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 10.79% in the past year. It has overperformed other stocks in the biotech industry by 87 percentage points.

3. United Therapeutics (NASDAQ:UTHR)

United Therapeutics (NASDAQ:UTHR) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

United Therapeutics has a valuation score of 43, which is 28 points higher than the biotech industry average of 15. It passed 3 out of 7 valuation due diligence checks.

United Therapeutics's stock has dropped -1.47% in the past year. It has overperformed other stocks in the biotech industry by 75 percentage points.

Are biotech stocks a good buy now?

53.31% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 99.94% over the next year.

2.39% of biotech stocks have a Zen Rating of A (Strong Buy), 4.56% of biotech stocks are rated B (Buy), 35.57% are rated C (Hold), 36.66% are rated D (Sell), and 20.82% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is -108.97x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Aurinia Pharmaceuticals (NASDAQ:AUPH)

2. Exelixis (NASDAQ:EXEL)

3. Catalyst Pharmaceuticals (NASDAQ:CPRX)

1. Dominari Holdings (NASDAQ:DOMH)

2. Novo Nordisk (Ozempic) (NYSE:NVO)

3. Royalty Pharma (NASDAQ:RPRX)

1. Puma Biotechnology (NASDAQ:PBYI)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. United Therapeutics (NASDAQ:UTHR)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2025)Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Aurinia Pharmaceuticals (NASDAQ:AUPH)

2. Exelixis (NASDAQ:EXEL)

3. Catalyst Pharmaceuticals (NASDAQ:CPRX)

1. Dominari Holdings (NASDAQ:DOMH)

2. Novo Nordisk (Ozempic) (NYSE:NVO)

3. Royalty Pharma (NASDAQ:RPRX)

1. Puma Biotechnology (NASDAQ:PBYI)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. United Therapeutics (NASDAQ:UTHR)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.